Picardi M, Vincenzi A. Is it time to increase the liposomal doxorubicin dosage for frontline therapy in young adults and adults with classic Hodgkin lymphoma? Comment on: “Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy?”. Haematologica; https://doi.org/10.3324/haematol.2026.301044 [Early view].